Restricted accessResearch articleFirst published online 2021-08
Evaluation of Risk Factors for Hepatitis C Virus Infection Among Philadelphia's Shelter-Bound,Homeless Population: Data from a Student-Run Hepatitis C Virus Screening Initiative
The objective was to assess risk factors for HCV specific to the shelter-bound homeless population of Philadelphia, Pennsylvania. This is a retrospective analysis of data obtained from 306 patients who received HCV antibody testing at 4 homeless shelters in Philadelphia between March 2017 and June 2019. Risk factors for HCV infection specific to this population were analyzed using Fischer exact tests. Fourteen (4.6%) of 306 patients screened positive for HCV infection. Risk factors for HCV infection among this shelter-bound homeless population included injection drug use, inhalation drug use, and tattoos obtained while incarcerated. Although an estimated 2.8% of the population of Philadelphia is infected with HCV, 4.6% of those screened in this program tested positive, highlighting the increased prevalence of HCV among the shelter-bound homeless population and the importance of assessing risks for HCV infection inherent to this specific population.
Get full access to this article
View all access options for this article.
References
1.
MaheshwariA, RayS, ThuluvathPJ. Acute hepatitis C. Lancet, 2008; 372:321–332.
2.
RosenbergES, RosenthalEM., HallEW, et al.Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016. JAMA Netw Open, 2018; 1:e186371.
3.
EdlinBR, EckhardtBJ, ShuMA, HolmbergSD, SwanT. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology, 2015; 62:1353–1363.
4.
Centers for Disease Control and Prevention. Viral hepatitis surveillance—United States, 2016. Atlanta, GA: US Department of Health and Human Services, 2018.
5.
YehiaBR, SchranzAJ, UmscheidCA, Lo ReV3rd. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS ONE, 2014; 9(7):e101554.
6.
TrooskinSB, PocetaJ, ToweyCM, et al.Results from a geographically focused, community-based HCV screening, linkage-to-care and patient navigation program. J Gen Intern Med, 2015; 30:950–957.
7.
CoyleC, MoormanAC, BartholomewT, et al.The hepatitis C virus care continuum: linkage to hepatitis C virus care and treatment among patients at an Urban Health Network, Philadelphia, PA. Hepatology, 2019; 70:476–486.
8.
BoktorS, HowsareC. Epidemiology of Hepatitis C in Philadelphia. Pennsylvania Department of Health. Change: A Leadership Summit on HCV Policy in Pennsylvania. Philadelphia, Pennsylvania, May 1, 2015.
9.
WhiteDAE, AndersonES, PfeilSK, TrivediTK, AlterHJ. Results of a rapid hepatitis C virus screening and diagnostic testing program in an Urban Emergency Department. Ann Emerg Med, 2016; 67:119–128.
10.
GelbergL, RobertsonMJ, AranguaL, et al.Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Public Health Rep, 2012; 127:407–421.
11.
NoskaAJ, BelperioPS, Loomis TPO-T, ooleTP, BackusLI. Engagement in the Hepatitis C care cascade among homeless Veterans, 2015. Public Health Rep, 2017; 132:136–139.
12.
Moyer VA;U.S.Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 2013; 159:349–357.
13.
BeijerU, WolfA, FazelS. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis, 2012; 12:859–870.
14.
SmithBD, MorganRL, BeckettGA, at al. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep, 2012; 61:1–32.
15.
NyamathiAM, DixonEL, RobbinsW, et al.Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med, 2002; 17:134–143.
16.
SchillieS, WesterC, OsborneM, WesolowskiL, RyersonAB. CDC recommendations for hepatitis C screening among adults—United States, 2020. MMWR Recomm Rep, 2020; 69:1–17.
17.
WHO. Guidelines Approved by the Guidelines Review Committee. Guidelines for the screening care and treatment of persons with chronic hepatitis C infection: updated version. Geneva: World Health Organization, 2016.
18.
ZampinoR, CoppolaN, SagnelliC, Di CaprioG, SagnelliE. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol 2015, 28; 7:2323–2330.
19.
MahowaldMK, LarneyS, ZallerND, et al.Characterizing the burden of hepatitis C infection among entrants to Pennsylvania state prisons, 2004 to 2012. J Correct Health Care, 2016; 22:41–45.
20.
TohmeRA, HolmbergSD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clinical Infectious Diseases, 2012; 54:1167–1178.
21.
HellardME, AitkenCK, HockingJS. Tattooing in prisons—not such a pretty picture. Am J Infect Control, 2007; 35:477–480.
22.
HeT, LiK, RobertsMS, et al.Prevention of hepatitis C by screening and treatment in US prisons. Ann Intern Med, 2016; 164:84–92.
23.
BeiserME, SmithK, IngemiM, MulliganE, BaggettTP. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston. Int J Drug Policy, 2019; 72:129–137.
24.
BartholomewTS, GrosgebauerK, HuynhK, CosT. Integration of hepatitis C treatment in a primary care federally qualified health center; Philadelphia, Pennsylvania, 2015–2017. Inf Dis, 2019; 12:1178633719841381.
25.
JonesEA, LinasBP, TruongV, BurgessJF, LasserKE. Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B drug pricing program. PLoS One, 2019; 14:e0213745.
26.
Office of Homeless Services. Point-in-time count PA-500 Philadelphia CoC. 2019. http://philadelphiaofficeofhomelessservices.org/wp-content/uploads/2019/05/Total-by-Household-Type.pdf accessed November18, 2020.
27.
O'DonnellJK, GladdenRM, SethP. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region—United States, 2006–2015. MMWR Morb Mortal Wkly Rep, 2017; 66:897–903.
